Tango Therapeutics, Inc.TNGXNASDAQ

Revenue (LTM)

$62M

+48.3% YoY

Net Income (LTM)

$-102M

+22.0% YoY

Free Cash Flow

$-140M

Revenue CAGR (5Y)

+52.1%

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	37	25↓32.9%	37↑46.9%	42↑15.2%	62↑48.3%
Gross Profit	37	25↓32.9%	37↑46.9%	42↑15.2%	60↑42.9%
Operating Income	-58	-111↓90.9%	-114↓2.8%	-146↓27.5%	-111↑23.6%
Net Income	-58	-108↓85.8%	-102↑5.9%	-130↓28.1%	-102↑22.0%
EBITDA	-57	-109↓91.1%	-112↓2.1%	-143↓28.0%	-109↑23.8%
EPS Diluted	-0.94	-1.23↓30.9%	-1.08↑12.2%	-1.19↓10.2%	-0.87↑26.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	143	60↓58.0%	66↑10.7%	70↑4.7%	112↑61.5%
Total Current Assets	492	375↓23.8%	347↓7.7%	266↓23.1%	354↑32.8%
Total Assets	500	436↓12.7%	403↓7.8%	316↓21.4%	399↑26.0%
Total Current Liabilities	41	56↑36.5%	46↓17.3%	38↓16.9%	22↓43.2%
Total Liabilities	155	187↑20.3%	149↓20.1%	117↓21.7%	53↓55.1%
Total Equity	345	249↓27.6%	253↑1.5%	200↓21.2%	346↑73.5%
Total Debt	2	41↑2636.6%	39↓5.4%	36↓6.2%	34↓8.0%
Net Debt	-141	-19↑86.7%	-27↓45.8%	-33↓20.3%	-79↓138.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-60	-109↓83.2%	-118↓8.2%	-132↓11.5%	-139↓5.6%
Capital Expenditure	-2	-8↓318.7%	-2↑80.2%	-1↑50.6%	-1↓39.0%
Free Cash Flow	-61	-117↓90.3%	-120↓2.3%	-132↓10.7%	-140↓5.8%
Stock-Based Comp	8	14↑81.7%	19↑34.1%	29↑51.5%	26↓8.5%
Net Change in Cash	114	-81↓170.9%	6↑107.2%	2↓60.9%	43↑1767.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance